QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
Log in
NYSEAMERICAN:SENS

Senseonics Stock Forecast, Price & News

$0.39
+0.02 (+5.42 %)
(As of 12/1/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.36
Now: $0.39
$0.40
50-Day Range N/A
52-Week Range
$0.35
Now: $0.39
$1.78
Volume3.45 million shs
Average Volume2.34 million shs
Market Capitalization$95.64 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Senseonics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.17 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:SENS
Previous SymbolNASDAQ:SENS
CUSIPN/A
CIKN/A
Phone+1-301-5157260
Employees191

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$95.64 million
Next Earnings Date3/11/2021 (Estimated)
OptionableOptionable
$0.39
+0.02 (+5.42 %)
(As of 12/1/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Senseonics (NYSEAMERICAN:SENS) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Senseonics?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Senseonics
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Senseonics?

Wall Street analysts have given Senseonics a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Senseonics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Senseonics' next earnings date?

Senseonics is scheduled to release its next quarterly earnings announcement on Thursday, March 11th 2021.
View our earnings forecast for Senseonics
.

How were Senseonics' earnings last quarter?

Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) issued its earnings results on Monday, November, 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.04.
View Senseonics' earnings history
.

What price target have analysts set for SENS?

8 Wall Street analysts have issued 12-month target prices for Senseonics' shares. Their forecasts range from $0.25 to $1.00. On average, they anticipate Senseonics' stock price to reach $0.73 in the next twelve months. This suggests a possible upside of 88.4% from the stock's current price.
View analysts' price targets for Senseonics
.

Who are some of Senseonics' key competitors?

What other stocks do shareholders of Senseonics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC), Advanced Micro Devices (AMD), Micron Technology (MU), Nabriva Therapeutics (NBRV), Sorrento Therapeutics (SRNE), Amarin (AMRN), Tandem Diabetes Care (TNDM), CytoDyn (CYDY), TransEnterix (TRXC) and TherapeuticsMD (TXMD).

Who are Senseonics' key executives?

Senseonics' management team includes the following people:
  • Dr. Timothy T. Goodnow, Pres, CEO & Director (Age 58, Pay $1M)
  • Dr. Mukul Jain, Chief Operating Officer (Age 47, Pay $595.17k)
  • Dr. Francine Ratner Kaufman, Chief Medical Officer & Director (Age 69, Pay $590.06k)
  • Mr. Nick B. Tressler M.B.A., CFO, Sec. & Treasurer (Age 47)

What is Senseonics' stock symbol?

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Who are Senseonics' major shareholders?

Senseonics' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include NEA Management Company LLC (5.86%), Raymond James & Associates (0.42%), Raymond James Financial Services Advisors Inc. (0.26%), ExodusPoint Capital Management LP (0.20%), Morgan Stanley (0.16%) and Jane Street Group LLC (0.04%).
View institutional ownership trends for Senseonics
.

Which major investors are selling Senseonics stock?

SENS stock was sold by a variety of institutional investors in the last quarter, including NEA Management Company LLC, Jane Street Group LLC, Morgan Stanley, and Raymond James & Associates.
View insider buying and selling activity for Senseonics
.

Which major investors are buying Senseonics stock?

SENS stock was purchased by a variety of institutional investors in the last quarter, including ExodusPoint Capital Management LP, Perkins Capital Management Inc., and Raymond James Financial Services Advisors Inc..
View insider buying and selling activity for Senseonics
.

How do I buy shares of Senseonics?

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Senseonics' stock price today?

One share of SENS stock can currently be purchased for approximately $0.39.

How big of a company is Senseonics?

Senseonics has a market capitalization of $95.64 million. Senseonics employs 191 workers across the globe.

What is Senseonics' official website?

The official website for Senseonics is www.senseonics.com.

How can I contact Senseonics?

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.

This page was last updated on 12/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.